Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Korkmaz, T.; Seber, S.; KEFELİ, UMUT; Sari, E.; Canhoroz, M.; Oven, B.; Yildirim, E.; Yasar, N.; Aydin, D.; Balvan, O.; Sener, N.; Yuksel, S.; Mert, A.; Polat, O.; YUMUK, PERRAN; Kanat, O.; Gumus, M.; Turhal, N.

doi:10.1007/s12094-012-0960-6

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Copy For Citation

Korkmaz T., Seber S., KEFELİ U., Sari E., Canhoroz M., Oven B., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, no.7, pp.535-540, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 15 Issue: 7
Publication Date: 2013
Doi Number: 10.1007/s12094-012-0960-6
Journal Name: CLINICAL & TRANSLATIONAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.535-540
Bursa Uludag University Affiliated: Yes

Abstract

Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.